Wu Wei-Xun, Huang Ming-Bin, Wang Mei-Xia, Chen Li-Hua, Hu Bo, Ding Zhen-Bin
Department of Liver Surgery, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361006, Fujian Province, China.
Department of Infection Management, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, Fujian Province, China.
World J Gastrointest Surg. 2025 Jan 27;17(1):101793. doi: 10.4240/wjgs.v17.i1.101793.
Improving the intraoperative and postoperative performance of laparoscopic hepatectomy was quite a challenge for liver surgeons.
To determine the benefits of indocyanine green (ICG) fluorescence imaging in patients with hepatocellular carcinoma (HCC) who underwent laparoscopic hepatectomy during and after surgery.
We retrospectively collected the clinicopathological data of 107 patients who successfully underwent laparoscopic hepatectomy at Zhongshan Hospital (Xiamen), Fudan University from June 2022 to June 2023. Whether using the ICG fluorescence imaging technique, we divided them into the ICG and non-ICG groups. To eliminate statistical bias, a 1:1 propensity score matching analysis was conducted. The comparison of perioperative outcomes, including inflammation-related markers and progression-free survival, was analyzed statistically.
Intraoperatively, the ICG group exhibited lower blood loss, a shorter surgical time, lower hepatic inflow occlusion (HIO) frequency, and a shorter total HIO time. Postoperatively, the participation of ICG resulted in a shorter duration of hospitalization (6.5 7.6 days, = 0.03) and postoperative inflammatory response attenuation (lower neutrophil-lymphocyte ratio on the first day after surgery and platelet-lymphocyte ratio on the third day, < 0.05). Although the differences were not significant, the levels of all inflammation-related markers were lower in the ICG group. The rates of postoperative complications and the survival analyses, including progression-free and overall survivals showed no significant difference between the groups.
The involvement of ICG fluorescence imaging may lead to improved perioperative outcomes, especially postoperative inflammatory response attenuation, and ultimately improve HCC patients' recovery after surgery.
改善腹腔镜肝切除术的术中及术后表现对肝脏外科医生来说是一项相当大的挑战。
确定吲哚菁绿(ICG)荧光成像在接受腹腔镜肝切除术的肝细胞癌(HCC)患者手术期间及术后的益处。
我们回顾性收集了2022年6月至2023年6月在复旦大学附属中山医院(厦门)成功接受腹腔镜肝切除术的107例患者的临床病理数据。根据是否使用ICG荧光成像技术,将他们分为ICG组和非ICG组。为消除统计偏差,进行了1:1倾向评分匹配分析。对围手术期结果进行统计学分析,包括炎症相关指标和无进展生存期。
术中,ICG组出血量更低、手术时间更短、肝血流阻断(HIO)频率更低、总HIO时间更短。术后,ICG的应用使住院时间缩短(6.5±7.6天,P = 0.03),术后炎症反应减轻(术后第一天中性粒细胞与淋巴细胞比值及术后第三天血小板与淋巴细胞比值更低,P < 0.05)。尽管差异不显著,但ICG组所有炎症相关指标水平更低。两组术后并发症发生率及生存分析,包括无进展生存期和总生存期均无显著差异。
ICG荧光成像的应用可能会改善围手术期结果,尤其是减轻术后炎症反应,并最终促进HCC患者术后恢复。